Tempest Therapeutics, Inc. financial statements
Tempest Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 26.26M | 10-K |
| Cash and equivalents | USD 7.71M | 10-Q |
| Total debt | USD 0 | 10-K |
Tempest Therapeutics, Inc. financials on 6ix · Tempest Therapeutics, Inc. on 6ix